Nina Capital

Nina Capital is a specialized venture capital firm founded in 2019 and headquartered in Barcelona, Spain. The firm focuses exclusively on investing at the intersection of healthcare and technology, aiming to support need-driven founders in improving health outcomes and care provision. Their investment areas include diagnostics, medical devices, clinician training, healthcare infrastructure, and data-driven clinical pathways.

In early 2025, Nina Capital closed its €50 million Fund III, bringing assets under management to over €100 million. This fund aims to invest in approximately 25 companies, with initial check sizes ranging from €250,000 to €1.5 million, and reserves allocated for follow-on investments. The fund's limited partners include Boston-based wealth management firm Seven Two Partners, as well as family offices and high-net-worth individuals from Europe and the United States.

Nina Capital employs a need-driven, value-based approach to healthcare innovation, informed by the Stanford Biodesign methodology. The firm seeks founders who combine a deep understanding of the complex healthcare ecosystem with engineering innovation, advanced data science, and IT-enabled products and services. Nina Capital aims to bridge the gap from founding to Series A, assisting startups in accessing global markets and scaling their solutions internationally.

As of October 2025, Nina Capital has invested in over 50 companies across nearly 20 countries, touching the lives of over 10 million people through healthcare technology innovations. Notable investments include Neurescue, Ultromics, Mindpeak, Earlysight, Adora, and Lillian Care. The firm has also achieved exits with companies such as Alfie Health and Replica Analytics.